BR9509297A - Composto composição farmacêutica utilização de um composto e processos de tratamento ou prolifaxia de uma doença ou condição na qual a síntese ou suprasintese da sintetase de óxido nitrico forma uma parte contribuinte e desordens neurodegenerativas ou de enxaqueca ou de prevenção e reversão da tolerância a opiatos e diazepinas ou de tratamento do vicio em tóxicos e de preparação de um composto - Google Patents
Composto composição farmacêutica utilização de um composto e processos de tratamento ou prolifaxia de uma doença ou condição na qual a síntese ou suprasintese da sintetase de óxido nitrico forma uma parte contribuinte e desordens neurodegenerativas ou de enxaqueca ou de prevenção e reversão da tolerância a opiatos e diazepinas ou de tratamento do vicio em tóxicos e de preparação de um compostoInfo
- Publication number
- BR9509297A BR9509297A BR9509297A BR9509297A BR9509297A BR 9509297 A BR9509297 A BR 9509297A BR 9509297 A BR9509297 A BR 9509297A BR 9509297 A BR9509297 A BR 9509297A BR 9509297 A BR9509297 A BR 9509297A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- treatment
- suprasynthesis
- toxics
- diazepines
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 3
- 206010012335 Dependence Diseases 0.000 title 1
- 208000019695 Migraine disease Diseases 0.000 title 1
- 102000008299 Nitric Oxide Synthase Human genes 0.000 title 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 150000004908 diazepines Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
- 230000000626 neurodegenerative effect Effects 0.000 title 1
- 229940127240 opiate Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 230000035755 proliferation Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 231100000167 toxic agent Toxicity 0.000 title 1
- 230000002588 toxic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB1995/001896 WO1997006158A1 (en) | 1995-08-10 | 1995-08-10 | Bicyclic amidine derivatives useful in therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9509297A true BR9509297A (pt) | 1998-07-07 |
Family
ID=10768883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9509297A BR9509297A (pt) | 1995-08-10 | 1995-08-10 | Composto composição farmacêutica utilização de um composto e processos de tratamento ou prolifaxia de uma doença ou condição na qual a síntese ou suprasintese da sintetase de óxido nitrico forma uma parte contribuinte e desordens neurodegenerativas ou de enxaqueca ou de prevenção e reversão da tolerância a opiatos e diazepinas ou de tratamento do vicio em tóxicos e de preparação de um composto |
Country Status (7)
| Country | Link |
|---|---|
| KR (1) | KR970706272A (cs) |
| BR (1) | BR9509297A (cs) |
| CZ (1) | CZ287969B6 (cs) |
| EE (1) | EE9700207A (cs) |
| IS (1) | IS4452A (cs) |
| SK (1) | SK281442B6 (cs) |
| WO (1) | WO1997006158A1 (cs) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9701681D0 (sv) * | 1997-05-05 | 1997-05-05 | Astra Ab | New compounds |
| US6166030A (en) * | 1997-05-05 | 2000-12-26 | Astra Aktiebolag | Compounds |
| DE19844291A1 (de) * | 1998-09-18 | 2000-03-23 | Schering Ag | Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln |
| SE9803710L (sv) | 1998-09-25 | 2000-03-26 | A & Science Invest Ab | Användning av vissa substanser för behandling av nervrotsskador |
| US7115557B2 (en) | 1998-09-25 | 2006-10-03 | Sciaticon Ab | Use of certain drugs for treating nerve root injury |
| EP1283199A4 (en) | 2000-05-16 | 2003-12-17 | Takeda Chemical Industries Ltd | MELANINE CONCENTRATING HORMONE ANTAGONISTS |
| TWI243164B (en) | 2001-02-13 | 2005-11-11 | Aventis Pharma Gmbh | Acylated indanyl amines and their use as pharmaceuticals |
| MY136316A (en) | 2001-02-13 | 2008-09-30 | Sanofi Aventis Deutschland | Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical. |
| DE60325025D1 (de) | 2002-02-15 | 2009-01-15 | Glaxo Group Ltd | Modulatoren des vanilloidrezeptors |
| EP1388535A1 (en) * | 2002-08-07 | 2004-02-11 | Aventis Pharma Deutschland GmbH | Acylated arylcycloalkylamines and their use as pharmaceuticals |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0690851B1 (en) * | 1993-03-23 | 1999-05-19 | Astra Aktiebolag | Guanidine derivatives useful in therapy |
| ATE231126T1 (de) * | 1993-08-12 | 2003-02-15 | Astrazeneca Ab | Amidin-derivate mit stickstoffoxid-synthease- aktivität |
| JPH10500138A (ja) * | 1994-05-07 | 1998-01-06 | アストラ・アクチエボラーグ | 酸化窒素合成酵素阻害剤としての２環アミジン誘導体 |
-
1995
- 1995-08-10 BR BR9509297A patent/BR9509297A/pt unknown
- 1995-08-10 SK SK390-97A patent/SK281442B6/sk unknown
- 1995-08-10 CZ CZ19971086A patent/CZ287969B6/cs not_active IP Right Cessation
- 1995-08-10 EE EE9700207A patent/EE9700207A/xx unknown
- 1995-08-10 KR KR1019970702315A patent/KR970706272A/ko not_active Ceased
- 1995-08-10 WO PCT/GB1995/001896 patent/WO1997006158A1/en not_active Application Discontinuation
-
1997
- 1997-03-25 IS IS4452A patent/IS4452A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK39097A3 (en) | 1998-08-05 |
| EE9700207A (et) | 1998-02-16 |
| CZ287969B6 (cs) | 2001-03-14 |
| KR970706272A (ko) | 1997-11-03 |
| SK281442B6 (sk) | 2001-03-12 |
| WO1997006158A1 (en) | 1997-02-20 |
| IS4452A (is) | 1997-03-25 |
| CZ108697A3 (cs) | 1998-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE05404B1 (et) | Kinuklidiini derivaat, selle saamine ja kasutamine ravimi valmistamiseks, mis on ette nhtud respiratoorsete, kuseelundite v?i mao-soolte haiguste ravimiseks, ning seda sisaldav ravimkompositsioon | |
| BR9709915A (pt) | Composto composição farmacêutica utilização do composto e processos para o tratamento ou a prevençao de distúrbios fisiológicos asociados com um excesso de taquiquininas e para preparação do composto | |
| BR9610248A (pt) | Composto composição farmacêutica processos para o tratamento da dor e para a preparação de um composto e uso do composto | |
| EE200300295A (et) | Kinuklidiinkarbamaadi derivaat, selle saamine ja kasutamine ravimi valmistamiseks, mis on ette nähtud respiratoorsete, kuseelundite või mao-soolte haiguste ravimiseks, ning seda sisaldav ravimkompositsioon | |
| BR9509297A (pt) | Composto composição farmacêutica utilização de um composto e processos de tratamento ou prolifaxia de uma doença ou condição na qual a síntese ou suprasintese da sintetase de óxido nitrico forma uma parte contribuinte e desordens neurodegenerativas ou de enxaqueca ou de prevenção e reversão da tolerância a opiatos e diazepinas ou de tratamento do vicio em tóxicos e de preparação de um composto | |
| EE200200046A (et) | 8-fenüül-6,9-dihüdro-[1,2,4]triasolo[3,4-i]puriin-5-ooni derivaat, selle valmistamine ja raviotstarbeline kasutamine ning seda sisaldav farmatseutiline kompositsioon | |
| HUP9901807A3 (en) | Heterocycle substituted n-acyl benzenesulfonamide derivatives, process for their preparation and their use as prodrug for the preparation of pharmaceutical compositions treating inflammation or inflammation-associated disorders | |
| IL122733A0 (en) | Pharmaceutical compositions for use in the treatment of allergic asthma | |
| BR0315283A (pt) | Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto, e, método de tratamento de doenças neurológicas ou de doenças inflamatórias do trato respiratório superior | |
| HUP0301815A3 (en) | Mono and disaccharide-based pharmaceutical composition for infections and other diseases and prophylactic and therapeutic treatment | |
| BR9507656A (pt) | Composto utilização de um composto composição farmacéutica e processos para o tratamento de um paciente que sofre de dor e para a preparação de um composto | |
| HUP9600834A1 (en) | Quinazoline derivatives, producing and using them for the treatment of hyperproliferative diseases in a mammal, and a pharmaceutical composition containing the compounds | |
| BR9707616A (pt) | Composto composiç o farmacéutica utilização de um composto e processo para a preparação de um composto para o tratamento ou profilaxia de distúrbios de deficiéncia intelectual ou profilaxia da doença de parkinson doença de huntington síndrome de tourette esclerose amiotrófica lateral ou distúrbios neurodegenerativos | |
| IL117957A0 (en) | Pharmaceutical compositions for the treatment of impotence | |
| HUP0301167A3 (en) | Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders, process for their preparation, pharmaceutical compositions containing them and their use | |
| IL127943A0 (en) | Pharmaceutical and cosmetic composition for the treatment of skin disorders | |
| ZA983602B (en) | Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination | |
| ZA98960B (en) | Pharmaceutical composition for treatment of synaptic dysfunction and related disease disorders | |
| HUP9904027A3 (en) | Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases | |
| EE04493B1 (et) | Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks | |
| IL153831A (en) | Pharmaceutical composition for therapy of neurodegenerative disease of the brain | |
| CA2294090A1 (en) | Method and product using sturgeon notochord for alleviating the symptoms of arthritis | |
| HUP0401325A3 (en) | Isoxazolopyridinones useful in the treatment of parkinson's disease, process for their preparation and pharmaceutical compositions containing the compounds | |
| HUP0004331A3 (en) | Use of phanquinone for producing pharmaceutical compositions for the treatment of alzheimer's disease and combined pharmaceutical compositions containing it | |
| HUP9903684A3 (en) | Use of olanzapine for the preparation of pharmaceutical compositions treating depression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |